Bridging agronomy and pharmacology the antidiabetic promise of Oldenlandia
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: The growing global burden of diabetes and the limitations of current treatments require sustainable alternatives. This study aims to evaluate the potential of the weedy genus Oldenlandia as a novel, sustainable resource for diabetes management by synthesizing evidence from agronomy, phytochemistry, and pharmacology. Methods: A systematic literature review was conducted using major scientific databases. A multidisciplinary search strategy was employed, and the collected data were integrated using narrative synthesis. Findings: The analysis shows that Oldenlandia species are resilient plants requiring low agricultural inputs. They are rich in bioactive compounds like iridoids and flavonoids, and preclinical studies confirm significant antidiabetic effects, including lowered blood glucose and reduced inflammation via mechanisms such as AMPK-NF-κB pathway modulation. Conclusion: Oldenlandia presents a promising and sustainable candidate for developing new antidiabetic therapies, bridging traditional use with scientific validation. Novelty/Originality: This review offers a novel, integrated perspective that simultaneously evaluates the agronomic feasibility and pharmacological potential of a weed for diabetes treatment, a unique approach not commonly found in existing literature.
Fields of Study & Subjects
Natural Antidiabetic Agents Studies
Medicinal Plant Research
Phytochemistry and Biological Activities
Publication details
- Journal / source
- Bioculture Journal
- Volume
- 3
- Issue
- 2
- Pages
- 105–125
- Publication date
- 30 January 2026
- Language
- EN